In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter DeYoung, CEO at Piramal Global Pharma.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering:

Peter DeYoung is Piramal Global Pharma's CEO, comprising Piramal Pharma Solutions and Piramal Critical Care business units. In his current role, Peter is responsible for steering strategy and driving profitable growth of these businesses. Before this, he spearheaded several leadership mandates at the Piramal Group, including the CEO of Piramal Critical Care and the President of Life Sciences.

Previously, Peter worked in various investing and consulting roles in healthcare in the USA, Europe and India. After graduating from Princeton, he joined McKinsey & Company in New York, where he worked on several projects for pharmaceutical and medical device companies. Later, he joined the Blackstone Group’s Private Equity Division in Mumbai, where he was part of the deal team for several significant transactions across a broad spectrum of industry sectors in India.

Peter holds a Master’s Degree in Business Administration from Stanford University (Arjay Miller Scholar), California, USA and a Bachelor of Science Degree in Engineering from Princeton University, New Jersey, USA (summa cum laude).

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.